The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Body composition as a predictor of sunitinib toxicity in patients with renal cell carcinoma.
Samantha Cushen
No relevant relationships to disclose
Aoife M Ryan
No relevant relationships to disclose
MinYuen Teo
No relevant relationships to disclose
Peter MacEneaney
No relevant relationships to disclose
Patrick McLaughlin
No relevant relationships to disclose
Frances Fitzpatrick
No relevant relationships to disclose
Nataliya Rozumna-Martynyuk
No relevant relationships to disclose
Raymond S. McDermott
No relevant relationships to disclose
Derek Gerard Power
No relevant relationships to disclose